Claim interpretation by the Boards of Appeal of the EPO

Similar documents
Drafting international applications with Europe in mind. Dr. Matthew Barton, UK and European patent attorney, Forresters

The EPO Enlarged Board of Appeal decides on dosage regimens (G2/08) and treatment by surgery (G1/07)

Patentable Subject Matter and Medical Use Claims in the Pharmaceutical Sector

FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law

CA/PL 7/99 Orig.: German Munich, SUBJECT: Revision of the EPC: Articles 52(4) and 54(5) President of the European Patent Office

The Same Invention or Not the Same Invention? Thorsten Bausch

Allowability of disclaimers before the European Patent Office

An introduction to European intellectual property rights

Suzannah K. Sundby. canady + lortz LLP. David Read. Differences between US and EU Patent Laws that Could Cost You and Your Startup.

Switzerland. Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal. 1. Small molecules

ARE EXPRESSED SEQUENCE TAGS PATENTABLE UNDER THE EUROPEAN PATENT CONVENTION? A PRACTITIONER'S VIEW

United States Court of Appeals for the Federal Circuit

Part II. Time limit for completing the International search. Application not searched

pct2ep.com Guide to claim amendment after EPO regional phase entry

The Patent Examination Manual. Section 10: Meaning of useful. Meaning of useful. No clear statement of utility. Specific utility

COMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 -

IPFocus LIFE SCIENCES 9TH EDITION WHEN IS POST-PUBLISHED EVIDENCE ACCEPTABLE? VALEA

It is all crystal clear by definition... (and don t blame us if it isn t)

Added matter under the EPC. Chris Gabriel Examiner Directorate 1222

Recent EPO Decisions: Part 1

The opposition procedure and limitation and revocation procedures

BRAZIL EXAMINATION GUIDELINES of Patent Applications Industrial Property Journal No.2241, December 17, 2013

Amendments in Europe and the United States

Foreign Patent Law. Why file foreign? Why NOT file foreign? Richard J. Melker

should disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art

Chapter 1 Requirements for Description

FORM 4. RULE 26(f) REPORT (PATENT CASES) UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position

Claim amendments - a case for national proceedings in the life science field?

News and analysis on IP law, regulation and policy from around the world. For the latest updates, visit

Dawn of an English Doctrine of Equivalents: immaterial variants infringe

Examination Guidelines for Patent Applications. Block I - Tittle, Specification, Claim Chart, Drawings and Abstract

FICPI 12 th Open Forum

Intellectual Property and crystalline forms. How to get a European Patent on crystalline forms?

COMPARATIVE STUDY REPORT REQUIREMENTS FOR DISCLOSURE AND CLAIMS - 1 -

Keywords: patent, construction, infringement, Amgen, equivalents, protocol

Partial Priorities and Transfer of Priority Rights. Dr. Joachim Renken

Construction of second medical use claims. The Hon. Mr Justice Richard Arnold

Doctrine of Equivalents: Recent Developments in Germany

Threats & Opportunities in Proceedings before the EPO with a brief update on the Unitary Patent

IP Report Patent Law. The right of priorities: Recent developments in EPO case law Reported by Dr. Rudolf Teschemacher

Guidebook. for Japanese Intellectual Property System 2 nd Edition

Maximizing Patent Prosecution Opportunities in Europe: Tactics for Counsel When Drafting U.S.-Origin Applications

How patents work An introduction for law students

Tools and Pitfalls Recent Decisions from the EPO Boards of Appeal 20 November 2014

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO)

Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University

PATENT COOPERATION TREATY (PCT)

BOARDS OF APPEAL OF THE EUROPEAN PATENT OFFICE. DECISION of 7 July 2005

Patent Prosecution Update

MULTIPLE AND PARTIAL PRIORITIES. Robert Watson FICPI 17 th Open Forum, Venice October 2017

RECENT CASE LAW OF THE EPO REGARDING SOFTWARE/BUSINESS METHOD- RELATED INVENTIONS

Working Guidelines Q217. The patentability criteria for inventive step / non-obviousness

Section 102: A Dead Letter For Qualifying Claims

to obtain for the working of the invention pertaining to the Patent. However, having received an examiner's decision of refusal dated January 6,

Disclaimers at the EPO

Topic 12: Priority Claims and Prior Art

Slide 13 What rights does a patent confer?

PATENT COOPERATION TREATY. Non-establishment of opinion with regard to novelty, inventive step and industrial applicability

11th Annual Patent Law Institute

Unity of inventions at the EPO - Amendments to rule 29 EPC

Aligning claim drafting and filing strategies to optimize protection in the EPO, GPTO and USPTO

The use of prosecution history in post-grant patent proceedings

FEDERAL CIRCUIT DECISIONS FOR WEEK ENDING AUGUST 25, 2017

Recent Situation of the Japanese Intellectual Property Protection Scheme

The nuts and bolts of oppositions and appeals. Henrik Skødt, European Patent Attorney

JETRO seminar. Recent Rule change and latest developments at the EPO:

4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA

PATENT DISCLOSURE: Meeting Expectations in the USPTO

Patent Claims. Formal requirements and allowable amendments. 2005Jaroslav Potuznik

How to get a European patent. Guide for applicants

HOW HIGH HAS THE BAR BEEN RAISED? THE AUSTRALIAN PATENT OFFICE ISSUES ITS FIRST OPPOSITION DECISION ON A POST RAISING THE BAR PATENT APPLICATION

Indirect infringement: a pan-european viewpoint

POST-GRANT AMENDMENT JOHN RICHARDS

EUROPEAN PATENT OFFICE Guidelines for Examination Part E - Guidelines on General Procedural Matters Amended in December, 2007

Paper 14 Tel: Entered: June 15, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Chapter 2 Amendment Adding New Matter (Patent Act Article 17bis(3))

Second medical use or indication claims

COMMENTARY. Europe s Landmark Decision on Stem Cell Patents, or: The Strict European View on Life. Introduction JONES DAY

Summary Report. Report Q189

Patenting Software-related Inventions according to the European Patent Convention

How Sequenom Lost Patent Protection For Fetal DNA Test

Second medical use or indication claims. [Please insert name last name in CAPITAL letters please]

CHAPTER V PATENT SPECIFICATION AND CLAIMS

Title: The patentability criterion of inventive step / non-obviousness

Board of Patent Appeals and Interferences Patent and Trademark Office (P.T.O.) *1 Ex Parte Miguel A. Estrada, Joseph A. Russo, and Thomas M.

COMMISSION OF THE EUROPEAN COMMUNITIES COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT

Presented by Karl Fink, Nikki Little, and Tim Maloney. AIPLA Corporate Practice Committee Breakfast Meeting May 18, 2016

Unitary patent and Unified Patent Court: the proposed framework

IP: Patent law & prosecution

EPO boards of appeal decisions. Date of decision 25 November 1987

Comparison between Opposition Systems in Europe and Japan

10 Strategic Drafting of Applications for U.S. Patents by Japanese Companies from an Enforcement Perspective

IPPT , TBA-EPO, AgrEvo. Technical Board of Appeal EPO, 12 september 1995, AgrEvo [T 939/92]

Act No. 435/2001 Coll. on Patents, Supplementary Protection Certificates and on Amendment of Some Acts as Amended (The Patent Act)

STATUS AND APPLICATIONS

PATENT COOPERATION TREATY PCT. INTERNATIONAL PRELIMINARY REPORT ON PATENTABILITY (Chapter II of the Patent Cooperation Treaty)

Art. 123(2) EPC ADDED MATTER A US Perspective. by Enrica Bruno Patent Attorney. Steinfl & Bruno LLP Intellectual Property Law

BOARDS OF APPEAL OF THE EUROPEAN PATENT OFFICE. Datasheet for the decision of 7 July 2011 IPC: A61K 31/565, A61K 31/585, A61P 15/00

Note concerning the Patentability of Computer-Related Inventions

Transcription:

Claim interpretation by the Boards of Appeal of the EPO UNION Round Table: How to Cope with Patent Scope - Literal Interpretation of Claims throughout Europe Munich, 26 February 2010 Dr. Rainer Moufang (Legal Member of the Boards of Appeal of the EPO)

OVERVIEW Claim interpretation at the EPO Examination procedure Opposition procedure General principles of claim interpretation - Relevance of Article 69 EPC - "Patent to be construed by a mind willing to understand" - Broadest reasonable interpretation? - Patent documents as its own dictionary Illustrative cases Specific issues Claim features relating to a use or purpose Limitation by implicit features

CLAIM INTERPRETATION IN THE EXAMINATION PROCEDURE Patent claims to be granted should satisfy requirement of legal certainty Relevance of Article 84 EPC - Claims shall define matter for which protection is sought - Claims must enable third parties to determine the protection conferred (see G 2/88, OJ EPO 1990, 93) Relevance of Article 83 EPC Undefined parameters Absence of information on measuring method Nevertheless claim interpretation issues also arise in grant procedure Correct technical understanding is essential Legal issues (e.g. with respect to product-by-process claims or use/purpose features)

CLAIM INTERPRETATION IN THE OPPOSITION PROCEDURE Situation similar to claim interpretation in national nullity proceedings Limited relevance of Article 84 EPC Article 84 EPC is no opposition ground However, amendments have to satisfy clarity requirement Article 83 EPC remains relevant Undefined parameters Absence of information on measuring method Need for construing claims when examining grounds of opposition Last stage of central proceedings with respect to European patent

GENERAL PRINCIPLES OF CLAIM INTERPRETATION Relevance of Article 69 EPC? Provision is concerned with extent of protection conferred by European patent Scope of protection normally not an issue for EPO organs (see T 442/91, T 740/96 and T 417/04)

GENERAL PRINCIPLES OF CLAIM INTERPRETATION Relevance of Article 69 in context of Article 123(3) EPC G 2/88 determination of extent of protection to be carried out in accordance with Article 69 EPC and its Protocol Need for "abstract" determination of scope of protection Task sometimes more complex than determining scope of protection in infringement suits "Slightest doubt" case law T 113/86 (voluntary amendments) T 1293/03 (in context of Article 123(2) EPC)

GENERAL PRINCIPLES OF CLAIM INTERPRETATION Relevance of Article 69 EPC outside Article 123(3) EPC Many decisions rely on Article 69 EPC T 23/86 (OJ EPO 1987, 316): Description and drawings used to interpret claim e.g. when objective assessment of content of claim has to be made to judge whether its subject-matter is novel and inventive T 374/08 of 22 October 2009: "Normal reading skills fail to provide full understanding and, invoking Article 69(1) EPC, description and figures are called upon for assistance"

GENERAL PRINCIPLES OF CLAIM INTERPRETATION Claim interpretation has to be reasonable Leading case: T 190/99 Patent to be construed by a mind willing to understand Skilled person should rule out interpretations which are illogical or which do not make technical sense Skilled person should try, with synthetical propensity, i.e. building up rather than tearing down, to arrive at interpretation of claim which is technically sensible and takes into account whole disclosure of patent

GENERAL PRINCIPLES OF CLAIM INTERPRETATION Claim interpretation has to be reasonable Statements made in T 190/99 frequently quoted in boards of appeal case law T 841/04 Skilled person would not give interpretation to claim which would contradict overall technical teaching of patent

GENERAL PRINCIPLES OF CLAIM INTERPRETATION Broadest reasonable claim interpretation? T 151/05 of 22 November 2007 Unclear claims to be interpreted broadly in opposition proceedings since "any ambiguous text must be construed against the interest of the person responsible for drafting it" T 1886/06 of 23 October 2009 If an undefined term is used in the claims, all the prior art has to be taken into account which may be of relevance for any possible technically meaningful interpretation of the undefined term

GENERAL PRINCIPLES OF CLAIM INTERPRETATION Broadest reasonable claim interpretation? T 567/08 of 28 September 2009: Legal certainty of claim which, by introduction of undisclosed ambiguous term, is amended to have multiple reasonable interpretations, is compromised when one of those interpretations relate to added subject-matter

GENERAL PRINCIPLES OF CLAIM INTERPRETATION Patent document as its own dictionary Terms in patent documents should be given their normal meaning in relevant art, unless description gives them a special meaning (see e.g. T 311/93 and T 1321/04)

ILLUSTRATIVE CASES T 857/06 (3.3.04) of 5 June 2008 "TNF binding protein II/YEDA" Claim 1, first alternative: "A Tumor Necrosis Factor (TNF) Binding Protein II (TBP II) in substantially purified form having the following features: (a) it inhibits the cytotoxic effect of TNF; and (b) it contains the following amino acid sequence... [= specific 11 amino acid sequence] " Term TBP II does not merely refer to any protein in general and must be given technical meaning in light of description TBP II = protein isolated from human urine having a molecular weight of about 30 kda and containing an amino acid sequence much longer than the 11 amino acid sequence of claim 1

ILLUSTRATIVE CASES T 1844/06 (3.3.04) of 24 April 2008 "Phosphatidylserines/CHEMI" Claim 1: A process for the preparation of phosphatidylserines of formula (I) comprising the reaction of phospatides of general formula (II) with serine, characterized in that the reaction medium is an aqueous dispersion and in that the reaction is carried out in the presence of one or more surfactants at a concentration lower than 0.4 g per gram of phospatide.

ILLUSTRATIVE CASES T 1844/06 (3.3.04) of 24 April 2008 "Phosphatidylserines/CHEMI" Expression aqueous dispersion means that the phospholipids do not undergo complete solubilization but are under the form of small particles held in water by agitation, the particles being the dispersed phase, while water, i.e. the suspending medium, is the continuous phase Technical claim interpretation of Board of Appeal differed from interpretation underlying national infringement/revocation proceedings in IT and was decisive for issues under Articles 54, 56 and 83 EPC

CLAIM INTERPRETATION SPECIFIC ISSUES Claim features relating to use or purpose Guidelines for the Examination in the EPO, C-III 4.13: If a claim commences with such words as: "Apparatus for carrying out the process etc..." this must be construed as meaning merely apparatus suitable for carrying out the process. Apparatus which otherwise possesses all of the features specified in the claims but which would be unsuitable for the stated purpose or would require modification to enable it to be so used, should normally not be considered as anticipating the claim.

CLAIM INTERPRETATION SPECIFIC ISSUES Guidelines for the Examination in the EPO, C-III 4.13 (continued): Similar considerations apply to a claim for a product for a particular use For example, if a claim refers to a "mold for molten steel", this implies certain limitations for the mold. Therefore, a plastic ice cube tray with a melting point much lower than that of steel would not come within the claim.

CLAIM INTERPRETATION SPECIFIC ISSUES Guidelines for the Examination in the EPO, C-III 4.13 (continued): Similarly, a claim to a substance or composition for a particular use should be construed as meaning a substance or composition which is in fact suitable for the stated use; a known product which prima facie is the same as the substance or composition defined in the claim, but which is in a form which would render it unsuitable for the stated use, would not deprive the claim of novelty. However, if the known product is in a form in which it is in fact suitable for the stated use, though it has never been described for that use, it would deprive the claim of novelty.

CLAIM INTERPRETATION SPECIFIC ISSUES T 352/94 Characteristics implied by the particular use of a device should be taken into account when deciding the novelty of the device Example: "hook for a crane" as compared with a known "fish hook" of similar shape, the differences in size being implied by the difference in use. Exception in Article 54(4) and (5) EPC Known substance or composition for use in a surgical, therapeutic or diagnostic method G 2/08 of 19 February 2010 (Dosage regime/abbott RESPIRATORY)

Limitation by implicit features? CLAIM INTERPRETATION SPECIFIC ISSUES T 1404/05 of 24 May 2007 Article 69 EPC and Protocol intended to assist patent proprietor in contending for a broader interpretation of a claim than perhaps its wording warranted, not for cutting down the scope of a claim In order to avoid objection under Article 100(b) EPC against vague claim which possibly reads on non-enabled constructions, claim needs to be explicitly restricted to an enabled construction

Limitation by implicit features? CLAIM INTERPRETATION SPECIFIC ISSUES T 1404/05 of 24 May 2007 (continued) To consider giving narrower protection than literal meaning of claim is matter for national court If in proceedings before EPO proprietor argues for narrower scope, this should be done on the basis of the wording of claim, not on the basis of something appearing only in description Proprietor has possibility to restrict the wording of claim to the meaning he is contending for

Limitation by implicit features? CLAIM INTERPRETATION SPECIFIC ISSUES T 1010/05 of 18 June 2008 Yoghurt (prior art) = protein hydrolysate (claim)? Since patent relates to making protein hydrolysate formulae for patients suffering from food allergy, term "hydrolysate" implies certain level of hydrolysis. No evidence that degree of hydrolysis in yoghurt reaches this threshold

Homepage of European Patent Office: epo.org Thank you for your attention!